Mtove, George
Kimani, Joshua
Kisinza, William
Makenga, Geofrey
Mangesho, Peter
Duparc, Stephan
Nakalembe, Miriam
Phiri, Kamija S.
Orrico, Russell
Rojo, Ricardo
Vandenbroucke, Pol
Funding for this research was provided by:
Pfizer
Article History
Received: 19 October 2016
Accepted: 7 February 2018
First Online: 22 March 2018
Authors’ information
: Not applicable
: The main trial was approved by ethics committees and regulatory authorities from the respective countries. Written informed consent was obtained from each participant recruited for the main trial.
: Not applicable
: George Mtove, Joshua Kimani, William Kisinza, Geofrey Makenga, Peter Mangesho, Miriam Nakalembe, and Kamija S. Phiri were investigators in the study to which this manuscript relates and received research funding from Pfizer related to the implementation and execution of the study objectives. Stephan Duparc is an employee of the Sponsoring Entity, Medicines for Malaria Venture. Russell Orrico, Ricardo Rojo, and Pol Vandenbroucke are employees of the Sponsoring Entity, Pfizer.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.